Stanley J. Marciniak
- Dermatology top 2%
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 5
- Psoriasis: Treatment and Pathogenesis 2
- Hematology top 5%
- Platelet Disorders and Treatments 4
- Erythropoietin and Anemia Treatment 2
- Internal Medicine top 10%
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 4
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Heparin-Induced Thrombocytopenia and Thrombosis 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- Mary Ann MascelliHugh M. DavisZhenhua XuHonghui ZhouPhilippe SzaparyCésar A. CalderónKatherine LiCraig L. Leonardi
- Cited by
- DermatologyImmunologyHematology
- Journals
- The Journal of Clinical Pharmacology (3 papers)American Heart Journal (3 papers)Therapeutic Advances in Musculoskeletal Disease (1 paper)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Stanley J. Marciniak
18 papers receiving 739 citations
Peers
Comparison fields: 5 of 72
- Dermatology 183
- Immunology 373
- Hematology 165
- Internal Medicine 41
- Rheumatology 150
Countries citing papers authored by Stanley J. Marciniak
This map shows the geographic impact of Stanley J. Marciniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley J. Marciniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley J. Marciniak more than expected).
Fields of papers citing papers by Stanley J. Marciniak
This network shows the impact of papers produced by Stanley J. Marciniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley J. Marciniak. The network helps show where Stanley J. Marciniak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stanley J. Marciniak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 3 | |
| 3 | 2020 | 10 | |
| 4 | 2020 | 4 | |
| 5 | 2017 | 8 | |
| 6 | 2016 | 65 | |
| 7 | 2015 | 63 | |
| 8 | 2014 | 10 | |
| 9 | 2014 | 235 | |
| 10 | 2013 | 3 | |
| 11 | 2008 | 31 | |
| 12 | 2007 | 149 | |
| 13 | 2005 | 1 | |
| 14 | 2002 | 52 | |
| 15 | 2002 | 75 | |
| 16 | 2001 | 26 | |
| 17 | 2000 | 34 | |
| 18 | 2000 | 2 | |
| 19 | 1998 | 2 |
About Stanley J. Marciniak
Stanley J. Marciniak is a scholar working on Immunology, Hematology and Rheumatology, having authored 19 papers that have together received 773 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), Biosimilars and Bioanalytical Methods (5 papers), Platelet Disorders and Treatments (4 papers), Systemic Lupus Erythematosus Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Erythropoietin and Anemia Treatment (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Dermatology (183 citations), Immunology (373 citations) and Hematology (165 citations). Stanley J. Marciniak has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Mary Ann Mascelli, Hugh M. Davis, Zhenhua Xu, Honghui Zhou, Philippe Szapary, César A. Calderón, Katherine Li, Craig L. Leonardi, Yasmine Wasfi and Esther Bouman‐Thio. Their work appears in journals such as The Journal of Clinical Pharmacology, American Heart Journal, Therapeutic Advances in Musculoskeletal Disease, Lupus and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.